Related Experiment Videos
Transdermal delivery of antisense oligonucleotides
Rhonda M Brand1, Patrick L Iversen
1Division of Emergency Medicine, Evanston Northwestern Healthcare, and Department of Medicine, Feinberg School of Medicine, Northwestern University, IL, USA.
Methods in Molecular Medicine
|September 18, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Mucosal tenofovir 1% gel stimulates cell proliferation and type I/III interferon pathways.
Microbiology spectrum·2026
UNSEG: unsupervised segmentation of cells and their nuclei in complex tissue samples.
Communications biology·2024
Methods for cancer gene therapy using tumor suppressor genes.
Methods in molecular medicine·2014
Suppression of the human carcinoma phenotype by an antioncogene ribozyme.
Methods in molecular medicine·2014
Methods for the use of stromal cells for therapeutic gene therapy.
Methods in molecular medicine·2014
Methods for adenovirus-mediated gene transfer to synovium in vivo.
Methods in molecular medicine·2014
Methods for gene transfer to synovium.
Methods in molecular medicine·2014
Methods for generation of genetically modified fibroblasts for immunotherapy of cancer.
Methods in molecular medicine·2014
Development of a Novel, Eco-Friendly Mechanical Cell Lysis Process Using Hollow Fiber Filter for AAV Manufacturing.
Biotechnology and bioengineering·2026
Programmed repair of disease-causing UGA premature termination codons in mammalian brain.
Nucleic acids research·2026
Case Report: Novel homozygous pathogenic variant of the SPG20 gene causes the Troyer syndrome in China.
Frontiers in genetics·2026
Molecular profiling and functional analyses of umbilical cord mesenchymal stem cell-derived extracellular vesicles for dry eye diseases.
Extracellular vesicles and circulating nucleic acids·2026
Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives.
Frontiers in immunology·2026
Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis After Failure of Ustekinumab: A Multicenter Retrospective Study.
The Journal of clinical and aesthetic dermatology·2026